BioSpace News Archive

Enzychem Lifesciences (KOSDAQ: 183490), a clinical-stage biopharmaceutical company developing innovative medicines to improve the lives of patients with cancer and inflammatory diseases, announced an oral presentation at the 2021 NASH-TAG Conference held virtually on March 11-13, 2021 .

February marked the celebration of No One Eats Alone Day, a nationwide initiative created by Beyond DifferencesTM, to promote inclusion among children and address social isolation.

ERT, the global leader in clinical endpoint data collection, today announced that Blue Earth Diagnostics has deployed its innovative imaging solution to support the evaluation of 18F-fluciclovine – a novel PET agent – for potential use in the detection of recurrent brain metastases

Castlight Health, Inc. (NYSE: CSLT), a leader in healthcare navigation, today announced a new COVID-19 vaccine navigation feature embedded directly into the Castlight app

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announces that it has entered into an agreement to acquire Costa Brazi

Stericycle, Inc. (NASDAQ: SRCL), a leading provider of medical waste and secure information destruction solutions, today announced that Chief Executive Officer Cindy Miller has joined more than 1,600 CEOs pledging to take action to advance diversity and inclusion in the workplace through the CEO Action for Diversity & InclusionTM coalition

Applied Botanics, LLC announced today it has appointed internationally known Naturopathic cancer expert, researcher, and author, Dr. Neil McKinney (Victoria, BC) to its existing panel of esteemed medical advisors

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today the second closing of its Series B equity financing, bringing the total amount raised in this round to $59 million and CARISMA’s total capital raised to date to nearly $121 million.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021

Rebus Biosystems, Inc., a life science technology company creating revolutionary tools to enable spatial omics research without compromise, today announced the launch of the Rebus Esper™ spatial omics platform.